Search results

This integrated process statement has been produced to explain how 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs) are developed. It provides an overview of the key process principles and describes all stages of development for ESUOMs

This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs

This manual describes the methods used by the Centre for Public Health Excellence (CPHE) in NICE to develop and update public health guidance

These are the main stages in the multiple technology appraisal process used before April 2018.

The key stages in development of our quality standards

Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

Agenda and papers of the NICE public board meeting on 13 December 2023

Agenda and papers of the NICE public board meeting on 16 December 2022

Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Learning disability settings {"@context":"http://schema

Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Mental health services {"@context":"http://schema.org"

NICE priority methodological research areas.

Home What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual)...

NICE Listens is our programme of deliberative public engagement. It's used to give us an understanding of public opinion on moral, ethical and social value issues.

Bisphosphonates for treating osteoporosis Patient decision aid What is osteoporosis and how can bisphosphonates help? Everyone's bones get weaker as...

Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.